Nuveen
BNTX icon

Nuveen’s BioNTech BNTX Stock Holding History

Nuveen’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-24,300
Closed -$4K – 3264
2022
Q1 		$4K Buy
+24,300
New +$4.08M ﹤0.01% 3334
2021
Q4 		– Sell
-24,300
Closed -$7K – 3330
2021
Q3 		$7K Hold
24,300
– – ﹤0.01% 3339
2021
Q2 		$5K Buy
+24,300
New +$4.58M ﹤0.01% 3308

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Nuveen's BNTX Position: Q2 2026 in Review

Nuveen opened a new position in BioNTech (BNTX) in Q2 2026: 3,994 shares worth $372K. The stake represents ﹤0.01% of the portfolio and ranks #3413 among its holdings. This is a return to the name: Nuveen previously reported a position in BNTX as recently as Q1 2023.

Nuveen first reported a position in BNTX in Q1 2021 and has held it in 10 quarters since. The position peaked at $51.3M in Q3 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Nuveen held 3,994 shares of BioNTech worth $372K as of Q2 2026.
  • BioNTech was a new Nuveen position in Q2 2026.
  • BioNTech made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3413 holding.
  • Nuveen first reported a position in BioNTech in Q1 2021 and has held it in 10 quarters since.
  • Nuveen's BioNTech position peaked at $51.3M in Q3 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.